9. GlaxoSmithKline

Total Ad Spend: $170.6 million
Television: $70.3 million
Magazine: $84.8 million
Other: $15.5 million

GlaxoSmithKline ($GSK) is counting on respiratory drugs to help get it through rough times and spent nearly 60% of its total advertising budget on the inhaler product Advair Diskus alone. It also backed up its fish-oil cholesterol pill Lovaza as a rival from Amarin hit the market.

In the spotlight

Advair Diskus, $99 million
Lovaza, $22.8 million
Jalyn, $14 million



Suggested Articles

Pfizer is doubling down on real-world data in HR-positive, HER2-negative breast cancer patients to boost its case for blockbuster Ibrance.

Sanofi, which has moved purposefully into high technologies to get more from its manufacturing, will lean even more on that strategy to save costs.

In a last-minute deal during North American trade talks, the Trump administration agreed to scrap rules protecting biologic drugs from copycat rivals.